» Articles » PMID: 18288940

AKT Signaling in Regulating Angiogenesis

Overview
Specialty Oncology
Date 2008 Feb 22
PMID 18288940
Citations 86
Authors
Affiliations
Soon will be listed here.
Abstract

AKT is a central signaling molecule in regulating cell survival, proliferation, tumor growth and angiogenesis. Upstream components of AKT signaling pathway such as PI3K, PTEN, and Ras are commonly mutated in many human cancers. Recently it is found that AKT plays an important role in regulating normal vascularization and pathological angiogenesis. Angiogenesis is required for tumor growth and metastasis when tumor reaches more than 1 mm in diameter. This review focuses on the role and potential mechanism of AKT signaling in regulating angiogenesis. Recent studies have shown that AKT activation is necessary and sufficient to regulate VEGF and HIF-1 expression in human cancer cells. VEGF and HIF-1 are potent inducers of angiogenesis. It was found that AKT activation induces VEGF and HIF-1 expression through its two downstream molecules HDM2 and p70S6K1. On the other hand, AKT transmits the upstream signals from growth factors, cytokines, heavy metals, and oncogenes for regulating VEGF and HIF-1 expression in human cancer cells. AKT activation and VEGF expression can be inhibited by different natural compounds used for cancer prevention. Thus, inhibition of AKT and its downstream targets offers a new approach for targeting angiogenesis, which could be important for the development of new cancer therapeutics in the future.

Citing Articles

Targeting HGF/c-MET signaling to regulate the tumor microenvironment: Implications for counteracting tumor immune evasion.

Xia Y, Huang C, Zhong M, Zhong H, Ruan R, Xiong J Cell Commun Signal. 2025; 23(1):46.

PMID: 39856684 PMC: 11762533. DOI: 10.1186/s12964-025-02033-1.


Phloridzin Docosahexaenoate, an Omega-3 Fatty Acid Ester of a Flavonoid Precursor, Inhibits Angiogenesis by Suppressing Endothelial Cell Proliferation, Migration, and Differentiation.

Fernando W, MacLean E, Monro S, Power Coombs M, Marcato P, Rupasinghe H Biomolecules. 2024; 14(7).

PMID: 39062483 PMC: 11274491. DOI: 10.3390/biom14070769.


Xuebijing improves intestinal microcirculation dysfunction in septic rats by regulating the VEGF-A/PI3K/Akt signaling pathway.

Tang A, Li Y, Sun L, Liu X, Gao N, Yan S World J Emerg Med. 2024; 15(3):206-213.

PMID: 38855370 PMC: 11153371. DOI: 10.5847/wjem.j.1920-8642.2024.035.


Pancreatic Cancer Treatment Targeting the HGF/c-MET Pathway: The MEK Inhibitor Trametinib.

Kim J, Lee T, Lee M, Cho I, Ryu J, Kim Y Cancers (Basel). 2024; 16(5).

PMID: 38473413 PMC: 10930669. DOI: 10.3390/cancers16051056.


Expression and association of vascular endothelial growth factor, vascular endothelial growth factor receptor, and phosphorylated signal transducer and activator of transcription factor 3 in malignant gliomas.

Edura P, Vokuda R, Ramamoorthi S, Srinivas B, Verma S, Sasidharan G J Neurosci Rural Pract. 2023; 14(4):723-728.

PMID: 38059258 PMC: 10696330. DOI: 10.25259/JNRP_155_2023.